Accuryn Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm

HAYWARD, Calif., Sept. 13, 2022 – Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. “We are excited about the designation, and what this means for patients, providers […] The post Accuryn Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm appeared first on Accuryn .